CAS 195514-23-9

AP1867

CAS: 195514-23-9

Fórmula: C₃₈H₄₇NO₁₁

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 693.7799

Ref: IN-DA01FW3I

2-(3-((R)-3-(3,4-Dimethoxyphenyl)-1-(((S)-1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carbonyl)oxy)propyl)phenoxy)acetic acid

CAS: 195514-23-9

2-(3-((R)-3-(3,4-Dimethoxyphenyl)-1-(((S)-1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carbonyl)oxy)propyl)phenoxy)acetic acid

Pureza: 98%

Peso molecular: 693.79g/mol

Ref: 54-OR1074866

AP1867

CAS: 195514-23-9

AP1867 is a small molecule that targets the protein–protein interactions of lipid kinases. It is being developed for the treatment of cancers, including breast, prostate and lung cancer. AP1867 has been shown to inhibit the growth of human cancer cells in tissue culture and animal models, with some effects on cell viability. AP1867 has also demonstrated an ability to induce genetic ablation in cultured cells and to modulate signal detection pathways. Target gene expression profiling has identified a number of potential molecular targets for this drug.

Fórmula: C₃₈H₄₇NO₁₁

Pureza: Min. 80%

Cor e Forma: Powder

Peso molecular: 693.8 g/mol

Ref: 3D-VHA51423

AP1867

CAS: 195514-23-9

AP1867 is a synthetic FKBP12F36V-directed ligand.

Fórmula: C₃₈H₄₇NO₁₁

Cor e Forma: Solid

Peso molecular: 693.78

Ref: TM-T14297